Comparison of Genomic Abnormalities and Gene Expression Analysis in Atypical, Ambiguous and Malignant Melanocytic Lesions

被引：0
|
作者：
Wang, Grace [1 ]
Wang, Min [1 ]
Alomari, Ahmed [1 ]
Andea, Aleodor [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
537
引用
收藏
页码：137A / 137A
页数：1
相关论文
共 50 条
  • [31] Paratumoral gene expression profiles: promising markers of malignancy in melanocytic lesions
    Diaz-Cano, S. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 702 - 703
  • [32] New immuno-histochemical markers for the differential diagnosis of atypical melanocytic lesions with uncertain malignant potential
    Marra, Laura
    Scognamiglio, Giosue
    Cantile, Monica
    Cerrone, Margherita
    De Murtas, Fara
    Sorrentino, Valeria
    Anniciello, Anna Maria
    Botti, Gerardo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [33] Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population
    Church, Alanna J.
    Moustafa, Danna
    Pinches, Robert Seth
    Hawryluk, Elena B.
    Schmidt, Birgitta A. R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 409 - 419
  • [34] tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities
    Miok, Viktorian
    Wilting, Saskia M.
    van de Wiel, Mark A.
    Jaspers, Annelieke
    van Noort, Paula I.
    Brakenhoff, Ruud H.
    Snijders, Peter J. F.
    Steenbergen, Renske D. M.
    van Wieringen, Wessel N.
    BMC BIOINFORMATICS, 2014, 15
  • [35] tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities
    Viktorian Miok
    Saskia M Wilting
    Mark A van de Wiel
    Annelieke Jaspers
    Paula I van Noort
    Ruud H Brakenhoff
    Peter JF Snijders
    Renske DM Steenbergen
    Wessel N van Wieringen
    BMC Bioinformatics, 15
  • [36] Expression of topoisomerase II alpha (Topo II) in benign and malignant melanocytic lesions.
    Mu, XC
    Jones, DM
    Tran, TA
    Ross, JS
    Carlson, JA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 61A - 61A
  • [37] INTERLEUKIN-2 RECEPTOR EXPRESSION IN BENIGN AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    KERNOHAN, NM
    SEWELL, HF
    JOURNAL OF PATHOLOGY, 1988, 155 (04): : A353 - A353
  • [38] MSG1 expression in benign and malignant Melanocytic lesions of skin and mucosa.
    Sedghizadeh, PP
    Williams, JD
    Allen, CM
    de la Chapelle, A
    Prasad, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (03) : 471 - 471
  • [39] MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium
    Sedghizadeh, PP
    Williams, JD
    Allen, CM
    Prasad, ML
    MEDICAL SCIENCE MONITOR, 2005, 11 (07): : BR189 - BR194
  • [40] INTERLEUKIN-2 RECEPTOR EXPRESSION IN BENIGN AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    KERNOHAN, NM
    SEWELL, HF
    JOURNAL OF PATHOLOGY, 1989, 157 (04): : 315 - 319
12345